Depression in Parkinson's disease: Brainstem midline alteration on transcranial sonography and magnetic resonance imaging

Journal of Neurology

Volumn 246, Issue 12, 1999, Pages 1186-1193

  Berg, Daniela ^a   Supprian, Tillmann ^a   Hofmann, Erich ^a   Zeiler, Björn ^d   Jäger, Andreas ^a   Lange, Klaus W ^b   Reiners, Karlheinz ^a   Becker, Thomas ^c   Becker, Georg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d NONE

Author keywords

Brainstem midline changes; Depression; Magnetic resonance imaging; Parkinson's disease; Transcranial sonography

Indexed keywords

AMANTADINE; AMITRIPTYLINE; BROMOCRIPTINE; BUDIPINE; CITALOPRAM; CLOMIPRAMINE; DIHYDROERGOCRYPTINE; DOXEPIN; FLUOXETINE; LEVODOPA; LISURIDE; MIRTAZAPINE; PAROXETINE; PERGOLIDE; ROPINIROLE; SELEGILINE; TOLCAPONE;

ADULT; AGED; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; LIMBIC SYSTEM; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PONS; PRIORITY JOURNAL;

AGED; BRAIN STEM; DEPRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MOVEMENT; PARKINSON DISEASE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0033395785     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050541     Document Type: Article

References (59)

1. 1. American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Association, Washington
2. 2. Austin MP, Dougall N, Ross M, O'Carroll RE, Moffoot A, Ebmeier KP, Goodwin GM (1992) Single photon emission tomography with 99mTC-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord 26 : 31-44
3. 3. Ball WA, Whybrow PC (1993) Biology of depression and mania. Curr Opin Psychiatry 6 : 27-34
4. 4. Baxter LR, Schwarz JM, Guze BH, Bergmann K, Suzbu MP (1990) PET imaging in obsessive compulsive disorders with and without depression. J Clin Psychiatry 51 : 61-69
5. 5. Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, Bogdahn U, Beckmann H (1995) Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38 : 180-184
6. 6. Becker G, Bogdahn U (1993) Transcranial color-coded real-time sonography. In: Babikian VL, Wechsler LR (eds) Transcranial Doppler ultrasonography. Mosby/Year Book, St. Louis, pp 51-66
7. 7. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial duplex-sonography. Neurology 45 : 182-184
8. 8. Becker G, Struck U, Bogdahn U, Becker T (1994) Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res 55 : 75-84
9. 9. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, Lindner A, Reichmann H, Riederer P, Beckmann H, Reiners K (1997) Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63 : 590-596
10. 10. Birkmayer W, Riederer P (1997) Biochemical post-mortem findings in depressed patients. J Neural Transm 37 : 95-109
11. 11. Carpenter MB, Sutin J (1993) Human neuroantomy. Williams and Wilkins, Baltimore
12. 12. Chan-Palay V, Asan E (1989) Quantitaion of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J Comp Neurol 287 : 373-392
13. 13. Chan-Palay V (1993) Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy. Adv Neurol 60 : 438-446
14. 14. Chia L-G, Cheng L-J, Chuo L-J, Cheng F-C, Cu J-S (1995) Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease. J Neurol Sci 133 : 73-78
15. 15. Collegium Internationale Psychiatriae Scalarum (1990) Rating scales for psychiatry. Beltz, Weinheim
16. 16. Cummings, JL (1992) Depression and Parkinson's disease: a review. Am J Psychiatry 149 : 443-454
17. 17. D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH (1987) Aminergic systems in Alzheimer's abd Parkinson's disease. Ann Neurol 22 : 229-236
18. 18. Deakin JF (1991) Depression and 5HT. Int Clin Psychopharmacol 6 [Suppl] 3 : 23-28
19. 19. Fibiger HC (1984. The neurobiological substrates of depression in Parkinson's disease. Can J Neurol Sci 11 : 105-107
20. 20. Geyer MA, Puerto A, Dawsey WJ, Knapp S, Bullard WP, Mandell AJ (1976) Histological and enzymatic studies of the mesolimbic and mesostriatal serotinergic pathways. Brain Res 106 : 241-256
21. 21. Glowinski J, Tassin JP, Thierry AM (1984) The meso-cortico-prefrontal dopaminergic neurons. Trends Neurosci 7 : 415-418
22. 22. Hillegaart V (1991) Functional topography of brain serotonergic pathways in rat. Acta Physiol Scand Suppl 598 : 1-54
23. 23. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17 : 427-442
24. 24. Hurwitz TA, Clark C, Murphy E, Klonoff H, Martin WR, Pate BD (1990) Regional cerebral glucose metabolism in major depressive disorder. Can J Psychiatry 35 : 684-688
25. 25. Jagust WJ, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA (1992) Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain 115 : 521-537
26. 26. Javoy-Agid F, Agid Y (1980) Is the mesocortical dopaminergic system involved in Parkinson's disease. Neurology 30 : 1326-1330
27. 27. Jones BE (1991) Noradrenergic locus coeruleus neurons: their relationship to neighboring (including cholinergic and GABAergic) neurons of the central grey and reticular formation. Prog Brain Res 88 : 15-30
28. 28. Kienzl E, Eichinger K, Sofic E, Jellinger K, Riederer P, Kuhn W, Fuchs G, Laux G (1990) Urinary dopamine sulfate: regulations and significance in neurological disorders. J Neural Transm Suppl 32 : 471-479
29. 29. Kitayama I, Nakamura S, Yaga T, Murase S, Nomura J, Kayahara T, Nakano K (1994) Degeneration of locus coeruleus axons in stress-induced depression model. Brain Res Bull 35 : 573-580
30. 30. Kostic VS, Djuricic BM, Covickovic-Sternic N, Bumbasirevic E, Nikolic M, Mrsulja BB (1987) Depression and Parkinson's disease: possible role of serotonergic mechanisms. J Neurol 234 : 94-96
31. 31. Kuhn W, Fuchs G, Laux G (1989) Clinical and biochemical characteristics in early depression in Parkinson's disease. In: Przuntek R, Riederer P eds. Early diagnosis and preventive therapy in Parkinson's disease. Springer, Vienna New York, pp 49-54
32. 32. Lang J (1993) Surgical anatomy of the brainstem. Neurosurg Clin N Am 3 : 367-403
33. 33. Levin BE, Llabre MM, Weiner WJ (1988) Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 51 : 1401-1404
34. 34. Mayberg HS, Starkstein SE, Peyser CE, Brandt J, Dannals RF, Folstein SE (1992) Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 42 : 1791-1797
35. 35. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, Wagner HN Jr, Robinson RG (1990) Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 28 : 57-64
36. 36. Mayeux R, Stern Y, Cote L, Williams JB (1984) Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 34 : 642-646
37. 37. Mayeux R, SternY, Williams JB, Cote L, Frantz A, Dyrenfurth I (1986) Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 143 : 756-759
38. 38. Mayeux R. Stern Y, Sano M, Williams JB, Cote L (1988) The relationship of serotonin to depression in Parkinson's disease. Mov Disord 3 : 237-244
39. 39. Menza MA, Margery HM (1994) Parkinson's disease and depression: the relationship to disability and personality. J Neuropsychiatry Clin Neurosci 6 : 165-169
40. 40. Montgomery GK, Reynolds NC, Warren MR (1985) Quantitative assessment of Parkinson's disease: study of reliability and data reduction with an abbreviated Columbia scale. Clin Neuropharmacol 8 : 83-92
41. 41. Nakamura S (1991) Axonal sprouting of the noradrenergic locus coeruleus neurons following repeated stress and antidepressant treatment. Prog Brain Res 88 : 587-598
42. 42. Niewenhuys R (1985) Chemoarchitecture of the brain. Springer Berlin Heidelberg New York, pp 144-158
43. 43. Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 50 : 743-755
44. 44. Phillips AG, Fibiger HS (1978) The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex. Can J Psychol 32 : 58-66
45. 45. Post RM, De Lisi LE, Holcomb HH, Uhde TW, Cohen R, Buchsbaum MS (1987) Glucose utilisation in the temporal cortex of affectively ill patients: positron emission tomography. Biol Psychiatry 22 : 545-553
46. 46. Randrup A, Munkvard I, Fof R (1975) Mania, depression, and brain dopamine. In: Essmann WB, Valzelli L (eds) Current developments in psychopharmacology. Spectrum, New York, pp 207-229
47. 47. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RJ, Dolan RJ (1994) Depression in Parkinson's disease. A positron emission study. Br J Psychiatry 165 : 333-339
48. 48. Sano M, Stern Y, Cote L, Williams JB, Mayeux R (1989) Depression in Parkinson's disease: a biochemical model. Neuropsychiatr Pract Opin 2 : 88-92
49. 49. Schildkraut JJ (1973) Neurophaarmacology of the affective disorders. Ann Rev Pharmacol 13 : 427-454
50. 50. Schöning M, Grunert D, Stier B (1989) Transkranielle Duplexsonographie durch den intakten Knochen: ein neues diagnostisches Verfahren. Ultraschall Med 10 : 66-71
51. 51. Simson PE, Weiss JM (1988) Altered activity of the locus coeruleus in an animal model of depression. Neuropsychopharmacology 1 : 287-295
52. 52. Starkstein SE, Preziosi TJ, Forrester AW, Robinson RG (1990) Specificity of affective and autonomic symptoms of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 53 : 869-873
53. 53. Torack RM, Morris JC (1986) Mesolimbocortical dementia: a clinicopathologic case study of a putative disorder. Arch Neurol 43 : 1074-1078
54. 54. Torrack RM, Morris JC (1988) The association of ventral tegmental area histopathology with adult dementia. Arch Neurol 45 : 497-501
55. 55. Ungerstedt U (1971) Stereotactic mapping of the monoamine pathways in rat brain. Acta Psychiatr Scand 367 : 1-48
56. 56. Van Praag HM, de Haan S (1979) Central serotonin metabolism and frequency of depression. Psychiatry Res 1 : 219-224
57. 57. Van Praag HM, Korf J, Lakke JP, Schut T (1975) Dopamine metabolising in depression, psychosis and Parkinson's disease: the problem od specificity of biological variables in behaviour disorders. Psychol Med 5 : 138-146
58. 58. Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson's disease. In: Streifler MB, Korzyn AD, Melamed E, Youdim MBH, eds. Parkinson's disease: anatomy, pathology and therapy. Adv Neurol 53 : 245-247
59. 59. Wehrli FF (1991) The basis of MR contrast. In: Scott W (ed) Magnetic resonance imaging of the brain an spine. Raven, New York, pp 23-29